Table 2.
p16− | p16+ | p-Value | PD-L1, CPS < 1 | PD-L1, CPS ≥ 1 | p-Value | |
---|---|---|---|---|---|---|
CD8+ TIL, n(%) | 0.005 * | 0.039 * | ||||
<1% | 51 (38.6) | 8 (29.6) | 48 (42.9) | 11 (23.9) | ||
≥1%, <5% | 50 (37.9) | 4 (14.8) | 39 (34.8) | 15 (32.6) | ||
≥5%, <10% | 14 (10.6) | 5 (18.5) | 11 (9.8) | 8 (17.4) | ||
≥10% | 17 (12.9) | 10 (37.0) | 14 (12.5) | 12 (26.1) | ||
PD-L1, n(%) | 0.596 | |||||
CPS < 1 | 94 (71.8) | 18 (66.7) | ||||
CPS ≥ 1 | 37 (28.2) | 9 (33.3) |
* p-Value < 0.05.